Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Non-Steroidal Anti-inflammatory Drugs Market From 2025 to 2029?
In recent times, the market size for non-steroidal anti-inflammatory drugs has experienced substantial growth. The market, valued at $20.68 billion in 2024, is expected to reach $21.89 billion in 2025, marking a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this historical growth include the prevalence of chronic inflammatory diseases, management of post-surgery pain, sport-related injuries, over-the-counter accessibility, an aging demographic, and heightened consumer awareness.
In the forthcoming years, a substantial surge is anticipated in the non-steroidal anti-inflammatory drugs market size. It is projected to expand to $28.15 billion in 2029, with an annual compound growth rate (CAGR) of 6.5%. Factors contributing to this growth include novel pain management therapies, regulatory amendments, the use of telehealth, global wellness tendencies, biosimilar rivalry, patient choices, and precision medicine tactics. Key forecasts for this period involve dominance of the over-the-counter (OTC) market, a growing inclination towards cox-2 inhibitors, generics and market competition, as well as the introduction of digital health technologies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
What Elements Are Contributing To Growth In The Non-Steroidal Anti-inflammatory Drugs Market?
An increase in chronic pain incidents is projected to fuel the expansion of the non-steroidal anti-inflammatory drugs market. Chronic pain, which lasts for over six months, often leads to the need for the use of non-steroidal anti-inflammatory drugs to alleviate injuries and chronic pain. For instance, in April 2022, the CDC (Centers for Disease Control and Prevention), a government agency based in the US, reported that arthritis, which affects numerous people in the US, is a common cause of chronic pain. About one in four adults suffering from arthritis, equating to around 15 million people, experience severe joint pain linked to the condition. Hence, the rising prevalence of chronic pain is propelling the non-steroidal anti-inflammatory drugs market forward.
Which Segments Are Detailed In The Global Non-Steroidal Anti-inflammatory Drugs Market Report?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
Which Emerging Trends And Strategic Shifts Are Shaping The Non-Steroidal Anti-inflammatory Drugs Market?
One of the primary trends in the non-steroidal anti-inflammatory drugs market is product innovation. Leading companies in the sector are focusing on developing novel technological solutions. Case in point, Endo International plc, a pharmaceutical company based in Ireland, debuted ibuprofen-famotidine 800 mg/26.6 mg tablets in March 2024. These tablets merge the pain-relieving and inflammation-reducing qualities of ibuprofen with the stomach-protecting effects of famotidine. The goal of this combination is to provide pain relief while simultaneously lowering the potential for gastrointestinal complications that can arise from the prolonged usage of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
Who Are The Key Contributors To Growth In The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company
Get The Full Report Here:
Which Region Is Projected To Lead The Non-Steroidal Anti-inflammatory Drugs Market By 2025?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
